MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions.

[1]  M. Trojano,et al.  Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration , 2014, PloS one.

[2]  R. Franklin,et al.  Macrophages and CNS remyelination , 2014, Journal of neurochemistry.

[3]  Jonas Bergquist,et al.  MALDI imaging of post‐mortem human spinal cord in amyotrophic lateral sclerosis , 2013, Journal of neurochemistry.

[4]  M. Chopp,et al.  Thymosin beta 4 mediates oligodendrocyte differentiation by upregulating p38 MAPK , 2012, Glia.

[5]  M. Chopp,et al.  Treatment of neurological injury with thymosin β4 , 2012, Annals of the New York Academy of Sciences.

[6]  M. Chopp,et al.  Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats. , 2012, Journal of neurosurgery.

[7]  H. Hartung,et al.  Enhancing remyelination in disease--can we wrap it up? , 2011, Brain : a journal of neurology.

[8]  C. Wegner,et al.  Inflammation, demyelination, and degeneration - recent insights from MS pathology. , 2011, Biochimica et biophysica acta.

[9]  M. Chopp,et al.  Thymosin β4 improves functional neurological outcome in a rat model of embolic stroke , 2010, Neuroscience.

[10]  Detlev Suckau,et al.  Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. , 2010, Journal of proteome research.

[11]  M. Chopp,et al.  Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis , 2009, Neuroscience.

[12]  F. Holsboer,et al.  Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis , 2009, Proteomics. Clinical applications.

[13]  Maxence Wisztorski,et al.  MALDI Imaging Mass Spectrometry , 2009, Molecular & Cellular Proteomics.

[14]  Sören-Oliver Deininger,et al.  MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. , 2008, Journal of proteome research.

[15]  R. Reti,et al.  Thymosin beta4 is cytoprotective in human gingival fibroblasts. , 2008, European journal of oral sciences.

[16]  Sergio E. Baranzini,et al.  Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets , 2008, Nature.

[17]  R. Reynolds,et al.  Remyelination can be extensive in multiple sclerosis despite a long disease course , 2007, Neuropathology and applied neurobiology.

[18]  T. Montine,et al.  Proteomic Identification of Novel Proteins in Cortical Lewy Bodies , 2007, Brain pathology.

[19]  R. Caprioli,et al.  Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. , 2007, Journal of mass spectrometry : JMS.

[20]  Hans Lassmann,et al.  Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.

[21]  Mahlon D. Johnson,et al.  Proteomics in Diagnostic Neuropathology , 2006, Journal of neuropathology and experimental neurology.

[22]  H. Lassmann,et al.  The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis , 2006, Neurological Sciences.

[23]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[24]  L. Bö,et al.  The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions , 2005, Journal of neuropathology and experimental neurology.

[25]  F. Holsboer,et al.  In-depth analysis of the human CSF proteome using protein prefractionation , 2004, Clinical Proteomics.

[26]  Richard M Caprioli,et al.  Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. , 2004, Journal of proteome research.

[27]  Frederik Barkhof,et al.  Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. , 2003, Archives of neurology.

[28]  A. Otto,et al.  beta-Thymosins, small acidic peptides with multiple functions. , 2001, The international journal of biochemistry & cell biology.

[29]  R. Wank,et al.  Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. , 1999, Journal of immunology.

[30]  Hans Lassmann,et al.  Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation? , 1999, The Journal of experimental medicine.

[31]  W. Brück,et al.  Macrophages in multiple sclerosis. , 1996, Immunobiology.

[32]  T. Hökfelt,et al.  Induction of Thymosin β4 mRNA Following Focal Brain Ischemia , 1996 .

[33]  L. Nencioni,et al.  Nerve Growth Factor Is an Autocrine Survival Factor for Memory B Lymphocytes , 1996, Cell.

[34]  H. Wacker,et al.  Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[35]  C. Barr,et al.  Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes. , 1987, Journal of immunology.